Click here for a message from The Motley Fool Co-Founders Tom and David Gardner.

Halozyme Therapeutics

HALO

HALO
Halozyme Therapeutics Stock Quote
$16.25 -$0.62 -3.7%
Price as of April 3, 2020, 4:30 p.m. EDT View Interactive HALO Charts

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.

Interactive Chart


News & Analysis: Halozyme Therapeutics

The Fool has written over 100 articles on Halozyme Therapeutics.

All

Market Moves

Earnings